To determine whether CDK6 is a common essential effector of oncogenic tyrosine kinases, we evaluated its contribution downstream of oncogenic KIT, a receptor closely related to FLT3 also involved in hematopoietic neoplasms. The gene discussed is KIT; the disease is hematopoietic and lymphoid cell neoplasm.